Friday 6 November 2026 Export AKBA’s income statement to Excel — free account

Akebia Therapeutics, Inc.

AKBA Healthcare Drug Manufacturers Specialty & Generic

Akebia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $236.2 million, up 47.5% from fiscal 2024.

Revenue: −37.2%
EPS: −2,600.0%
Free cash flow: −94.2%
Total debt: +5.52%

Quarter to September 2026, against a year earlier

Insider buying

0.41 0.02 −4.65%

Follow AKBA

Alert me

Market cap: $117.9M
P/E: 0.0×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 7/9
Altman Z: −4.42
Beneish M: −3.16
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	3	5	6	7	+8 more TTM periods Free account
ROE Full definition →	(143.83%)	(109.38%)	(78.96%)	64.49%
ROA Full definition →	(12.62%)	(8.53%)	(6.10%)	(1.79%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(73.24%)	(42.26%)	(29.07%)	(5.86%)
Average Days of Receivables Full definition →	67.45	89.15	98.22	72.68
Free Cash Flow per Share Full definition →	0.05	0.15	0.22	0.26
Free Cash Flow Full definition →	13.86	40.26	60.04	67.87
Capital Expenditures Full definition →	(1.92)	(1.29)	(0.33)	(0.12)
Other line items
Cash ROIC Full definition →	6.03%	17.50%	25.13%	25.54%
Accounts Receivable Turnover Full definition →	3.84	3.47	3.75	5.80
Accounts Payable Turnover Full definition →	4.70	4.26	4.19	2.17
Inventory Turnover Full definition →	2.23	3.00	2.70	2.48
Average Days of Payables Full definition →	66.77	77.05	69.37	195.95
Days of Inventory on Hand Full definition →	164.05	106.46	107.50	144.38
Tax Rate Full definition →	0.03	0.07	0.00	(0.38)
Research and Development Expense of Revenue Full definition →	36.36%	32.16%	29.01%	26.40%
Selling, General and Administrative Expense of Revenue Full definition →	54.88%	51.94%	48.27%	45.50%
Share Based Compensation of Revenue Full definition →	6.54%	6.08%	5.49%	4.78%
Interest Coverage Full definition →	(1.97)	(0.87)	0.25	0.97
Operating CF/Net income Full definition →	(0.35)	(1.40)	(2.94)	(12.72)
Depreciation/Fixed assets Full definition →	0.00	1.03	1.34	1.04
Capex/Depreciation Full definition →	0.00	(0.83)	(0.26)	(0.09)
Revenue per Share Full definition →	0.71	0.81	0.87	0.92
Operating CF per Share Full definition →	0.06	0.15	0.23	0.26
Capex per Share Full definition →	(0.01)	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.01	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly